What laboratory tests should be obtained in an adult patient after return of spontaneous circulation following cardiac arrest?

Post-Cardiac Arrest Laboratory Testing

Obtain a comprehensive metabolic panel, serum troponin, arterial blood gas, lactate, complete blood count, coagulation studies, and urine toxicology screen immediately after return of spontaneous circulation (ROSC) in all adult cardiac arrest patients.

Essential Initial Laboratory Tests

Core Metabolic and Cardiac Markers

• Basic metabolic profile should be obtained immediately to assess electrolyte abnormalities (particularly potassium, calcium, magnesium), renal function, and glucose levels that may have precipitated or complicated the arrest 1
• Serum troponin is essential to identify acute myocardial infarction as the precipitating cause and guide decisions about emergency coronary angiography 1
• Arterial blood gas (ABG) analysis should be obtained promptly after ROSC and within 10-15 minutes of establishing mechanical ventilation to guide oxygenation and ventilation targets 2
• Serum lactate is a critical prognostic marker, with levels >12.0 mmol/L associated with significantly lower likelihood of sustained ROSC 3

Hematologic and Coagulation Assessment

• Complete blood count (CBC) helps identify anemia, infection, or hematologic abnormalities that may complicate post-arrest care 4
• Coagulation studies (PT/INR, aPTT) are important because coagulopathy is commonly observed in cardiac arrest patients and affects management decisions 3
• Thromboelastometry or viscoelastic testing may provide additional prognostic information, with clot firmness parameters (A30 ≥48.0 mm on EXTEM) associated with higher likelihood of ROSC 3

Toxicology and Infection Screening

• Urine toxicology screen is essential to identify drug overdose (including opioids and QT-prolonging medications) as a reversible cause, particularly in younger patients 1
• Blood cultures should be obtained early, as up to 70% of post-cardiac arrest patients develop early infection, with the respiratory tract being the most common source 4

Prognostic Biomarkers (Timing-Dependent)

Neuron-Specific Enolase (NSE)

• NSE levels within 72 hours after ROSC, in combination with other tests, should be used for predicting neurological outcome in comatose patients, though no specific threshold value can be recommended 5
• This is a weak recommendation with very low-certainty evidence, so NSE should never be used in isolation for prognostication 5

Biomarkers NOT Recommended

• S-100B protein is suggested against for predicting neurological outcome due to low specificity 5
• Glial fibrillary acidic protein, serum tau protein, and neurofilament light chain are not recommended for prognostication due to insufficient evidence 5

Additional Diagnostic Studies

Imaging and Monitoring

• 12-lead electrocardiogram should be obtained as soon as possible after ROSC to identify ST-segment elevation requiring emergency coronary angiography 5
• Chest x-ray is essential to assess for aspiration, pulmonary edema, pneumothorax, and proper placement of endotracheal tube and central lines 1
• Head-to-pelvis computed tomography should be performed to identify reversible causes such as intracranial hemorrhage, pulmonary embolism, or aortic dissection 1
• Bedside ultrasound (point-of-care echocardiography) should assess for pericardial tamponade, aortic dissection, hemorrhage, and structural heart disease 1

Advanced Cardiac Evaluation

• Transthoracic echocardiography should be performed if initial evaluation does not reveal the cause, to screen for structural heart disease (cardiomyopathy) or valvular disease (mitral valve prolapse) that can precipitate sudden cardiac death 1

Timing and Monitoring Strategy

Immediate Post-ROSC (Within Minutes)

• Draw blood for metabolic panel, troponin, lactate, CBC, coagulation studies, and blood cultures simultaneously with establishing vascular access 1, 3
• Obtain arterial blood gas within 10-15 minutes of establishing mechanical ventilation 2
• Perform 12-lead ECG immediately 5

Early Post-ROSC (Within Hours)

• Repeat arterial blood gas to confirm achievement of target PaCO₂ (35-45 mmHg) and PaO₂ (targeting SpO₂ 92-98%) 2
• Obtain urine toxicology screen 1
• Perform imaging studies (chest x-ray, CT scan, echocardiography) 1

Delayed Assessment (≥72 Hours)

• Measure NSE levels in comatose patients as part of multimodal prognostication, but only in combination with clinical examination, electrophysiology, and neuroimaging 5

Common Pitfalls to Avoid

• Do not delay laboratory testing while waiting for vascular access—obtain blood samples as soon as IV or IO access is established during or immediately after resuscitation 1
• Do not rely on a single biomarker for prognostication; NSE and other markers must be used in combination with clinical examination, neurophysiology, and imaging 5
• Do not assume normal initial troponin excludes acute coronary syndrome—serial troponins may be needed, and coronary angiography decisions should be based on ECG findings and clinical presentation 5
• Avoid using S-100B protein for prognostication due to poor specificity 5
• Do not overlook toxicology screening in younger patients or those without obvious cardiac etiology, as drug overdose is a common reversible cause 1
• Temperature-correct blood gas values when interpreting PaCO₂ in hypothermic patients, as hypothermia increases reported PaCO₂ values above actual patient levels 2